Article
Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients.
Journal of molecular medicine (Berlin, Germany) - 1 May 1995
Villa E, Buttafoco P, Merighi A, Grottola A, Ferretti I, Ferrari A, Callea F, Trande P, Rebecchi A M, Manenti F
Abstract excerpt
The behavior of hepatitis C virus (HCV) infection with regards to type and number of HCV genotypes (tested with genotype-specific nested polymerase chain reaction) was evaluated in 60 patients with anti-HCV-positive chronic active hepatitis without cirrhosis [17 untreated and 43 subjects undergoing single or repeat courses of interferon (IFN) therapy] during a mean follow-up period of 76 +/- 18 months. In...
Topics
- Adult
- Evaluation Studies as Topic
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus
- Hepatitis Antibodies
- Hepatitis C
- Hepatitis C Antibodies
- Humans
- Interferon alpha-2
